Executives On The Move: Aadi Bioscience, Viatris and More
Executive Summary
Recent executive moves in the industry include C-suite changes at Aadi Bioscience and Simcere Pharmaceutical. Meanwhile, new directors were appointed at Viatris and Catalyst Biosciences.
You may also be interested in...
Pipeline Watch: Five Approvals And 15 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Executives On The Move: AVEO Pharmaceuticals, Everest Medicines and More
Recent executive changes in the industry include C-suite changes at Aveo Pharmaceuticals and Scandion Oncology. Meanwhile, new directors were appointed at Akston Biosciences and Everest Medicines.
Pipeline Watch: 10 Approvals And Nine Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.